The database uses publicly available study results to compare the viability of potential treatments and vaccines for COVID-19, including their safety, efficacy, and risk factors. It currently contains results from 68 studies on COVID-19 therapeutics and will ultimately include data from more than 500 registered studies.

The COVID-19 Clinical Outcomes database can be found on Certara's Clinical Outcomes Database Explorer (CODEx) interactive interface. Interested users must register through the COVID-19 Pharmacology Resource Center.

The database is funded by the COVID-19 Therapeutics Accelerator, an initiative of the Bill and Melinda Gates Foundation, Wellcome, Matercard, and others.

Addressing the COVID-19 challenge with computer modeling & simulation
Each day, we wake up hoping for positive news about vaccines and therapies to combat COVID-19. More than 70 candidate molecules are being evaluated for...

New tools rapidly detect anti-SARS-CoV-2 antibodies
New tools using surrogate viruses may be useful for rapid testing to determine whether antibodies effectively neutralize SARS-CoV-2. The viral vector-based...

Pfizer, BioNTech get $1.95B for SARS-CoV-2 vaccine
Pfizer and BioNtech have inked an agreement with the U.S. Department of Health and Human Services and the Department of Defense, as part of the federal...

PerkinElmer launches free COVID-19 data dashboards
PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

Certara, DMTC study preventative use of chloroquine for COVID-19
Certara and DMTC have entered into a research collaboration to evaluate the preventative use of chloroquine in healthcare workers at risk of infection...